REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • July 5th, 2006 • Medimmune Inc /De • Biological products, (no disgnostic substances) • New York
THIS REGISTRATION RIGHTS AGREEMENT (the “Agreement”) is made and entered into as of June 28, 2006, by and between MedImmune, Inc., a Delaware corporation (the “Company”), and UBS Securities LLC and Merrill Lynch, Pierce, Fenner & Smith Incorporated, as representatives of the several initial purchasers (the “Initial Purchasers”) named in Schedule A to the Purchase Agreement dated as of June 22, 2006 (the “Purchase Agreement”) between the Company and the Initial Purchasers.
